Open conformers of the non-classical and monomorphic major histocompatibility complex (MHC) class I molecule HLA-F are ligands for the activating receptor KIR3DS1 and trigger the activation of natural killer (NK) cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Parham, P. Immunol. Rev. 267, 1–5 (2015).
Della Chiesa, M., Sivori, S., Carlomagno, S., Moretta, L. & Moretta, A. Front. Immunol. 6, 573 (2015).
Garcia-Beltran, W.F. Nat Immunol 17, 1067–1074 (2016).
Vivier, E., Nunès, J.A. & Vély, F. Science 306, 1517–1519 (2004).
Goodridge, J.P., Burian, A., Lee, N. & Geraghty, D.E. J. Immunol. 191, 3553–3562 (2013).
Lepin, E.J. et al. Eur. J. Immunol. 30, 3552–3561 (2000).
Lee, N., Ishitani, A. & Geraghty, D.E. Eur. J. Immunol. 40, 2308–2318 (2010).
Raulet, D.H., Gasser, S., Gowen, B.G., Deng, W. & Jung, H. Annu. Rev. Immunol. 31, 413–441 (2013).
Martin, M.P. et al. Nat. Genet. 31, 429–434 (2002).
Pascal, V. et al. J. Immunol. 179, 1625–1633 (2007).
Ishigami, S. et al. Anticancer Res. 35, 2279–2285 (2015).
Harada, A. et al. Pathol. Int. 65, 569–574 (2015).
Jucaud, V. et al. Clin. Exp. Immunol. 183, 326–340 (2016).
Song, S. et al. Nat. Med. 22, 397–403 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
E.V. is a co-founder and shareholder of Innate-Pharma.
Rights and permissions
About this article
Cite this article
Vély, F., Golub, R. & Vivier, E. HLA-Fatal attraction. Nat Immunol 17, 1012–1014 (2016). https://doi.org/10.1038/ni.3541
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.3541